Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?

    Access Status
    Open access via publisher
    Authors
    Wong, G.
    Chakera, Aron
    Chapman, J.
    Chadban, S.
    Pilmore, H.
    Craig, J.
    Lim, W.
    Date
    2017
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Wong, G. and Chakera, A. and Chapman, J. and Chadban, S. and Pilmore, H. and Craig, J. and Lim, W. 2017. Cytomegalovirus and cancer after kidney transplantation: Role of the human leukocyte antigen system?. Transplant Infectious Disease. 19 (1).
    Source Title
    Transplant Infectious Disease
    DOI
    10.1111/tid.12631
    ISSN
    1398-2273
    School
    Curtin Medical School
    URI
    http://hdl.handle.net/20.500.11937/52835
    Collection
    • Curtin Research Publications
    Abstract

    © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons LtdBackground: The role of cytomegalovirus (CMV) in cancer development after transplantation remains uncertain. We aimed to determine the association between donor and recipient CMV serological status and the risk of cancer development after kidney transplantation. Methods: Using data from the Australian and New Zealand Dialysis and Transplant (ANZDATA) Registry, we assessed the association between CMV donor/recipient (D/R) serological status and the risk of solid organ cancers in primary adult deceased-donor kidney transplant patients between 1990 and 2012. Results: Of 8140 recipients, a total of 895 (11%) recipients developed incident cancers during a follow-up time of 51 555 person-years. Human leukocyte antigen (HLA) mismatches was an effect modifier between CMV serological status and cancer (P=.03 for interaction). In recipients who have received 0-2 HLA-ABDR mismatched kidneys, the adjusted hazard ratios for cancer incidence among those with CMV D-/R-, CMV D-/R+, and CMV D+/R- were 0.47 (95% confidence interval [CI]: 0.24-0.91), 1.42 (95% CI: 0.97-2.07), and 1.02 (95% CI: 0.67-1.57), respectively compared with the reference of CMV D+/R+. A similar association was not observed in those with >2 HLA-ABDR mismatches. Conclusion: CMV D-/R- status was associated with a reduced risk of cancer in kidney transplant recipients who have received well-matched renal allografts, suggesting a potential role of HLA matching in cancer development.

    Related items

    Showing items related by title, author, creator and subject.

    • Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
      Selvey, Linda; Lim, W.; Boan, P.; Swaminathan, R.; Slimings, C.; Harrison, Amy; Chakera, A. (2017)
      Background: Cytomegalovirus (CMV) establishes a lifelong infection that is efficiently controlled by the immune system; this infection can be reactivated in case of immunosuppression such as following solid organ ...
    • Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause
      Lim, W.; Wong, G.; McDonald, S.; Chakera, Aron; Luxton, G.; Isbel, N.; Pilmore, H.; Barbour, T.; Hughes, P.; Chadban, S. (2018)
      People with biopsy-proven glomerulonephritis (GN) as their cause of end-stage kidney disease (ESKD) who undergo kidney transplantation incur significant risk of recurrent GN-related graft failure, but the risk in recipients ...
    • Implantable Doppler Probe as a Vascular Monitoring Device in Kidney Transplant Patients: Investigation of Use at a Single Center
      Malik, M.S.; Akoh, J.; Aroori, S.; Latour, Jos (2022)
      Objectives: Vascular complications account for 30% to 35% of total kidney grafts lost during the first 3 months posttransplant. Early detection of vascular complications allows an opportunity for prompt intervention, which ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.